Stay informed about the latest breakthroughs in clinical research, FDA approvals, and healthcare innovation.
The FDA has approved suzetrigine, the first non-opioid pain medication for moderate-to-severe acute pain, addressing a critical need for non-addictive pain management alternatives.
Revolutionary gene-editing platforms developed by researchers are enabling custom gene editing for rare metabolic disorders, representing significant strides in genetic medicine.
A comprehensive guide to the questions you should ask and factors to consider when evaluating a clinical trial opportunity, including new FDA expedited pathways.
In 2025, the FDA approved 46 novel drugs. Learn how Phase 3 trials work and why they're the crucial final step before a treatment reaches patients.
Why diverse participation matters for medical research, how it impacts treatment outcomes, and what researchers are doing to make trials more inclusive.
Artificial intelligence is transforming how patients find clinical trials, analyzing vast datasets for personalized matching and accelerating the path to new treatments.
Several highly anticipated weight loss treatments are pending FDA approval, including oral GLP-1 drugs like orforglipron that could offer more accessible alternatives to injectables.
Yeztugo (lenacapavir), a revolutionary twice-yearly injectable for HIV pre-exposure prophylaxis (PrEP), has been approved, offering a significant advancement in AIDS prevention.
📚 Our articles are based on peer-reviewed research, FDA announcements, and trusted healthcare sources including FDA.gov, ClinicalTrials.gov, Harvard Medical School, NIH, and leading medical journals.
Get the latest clinical trial news, FDA approvals, and breakthrough research delivered to your inbox weekly.
We respect your privacy. Unsubscribe at any time.